Startups | Crain's

Business news covering the entrepreneurial culture and new business ventures.

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

Nikhil Hasija

Background:  

All in good taste: Sacramento has a really odd sweet tooth

America’s fondness for jelly beans runs the gamut – from traditional varieties such as apple, watermelon and cherry, to acquired tastes such as black licorice and buttered popcorn. | Photo courtesy of CandyStore.com

March 21, 2018 - 3:26pm

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

Mike Lu

Background:  

Lose the booze? Millennials aren’t enticed by Mad Men-era office perks

 Anthony Klotz, an assistant professor in the College of Business at OSU and lead author of workplace research on alcohol, says it can be a divisive issue in the workplace, and may actually be a deterrent for some potential employees. | Photo courtesy of Oregon State University.

March 19, 2018 - 5:50pm

Smart pill, other Florida innovations could aid opioid fight

EtectRx's smart pill contains a wireless, ingestible sensor that communicates with a wearable reader, which then delivers data to healthcare providers looking to monitor opioid adherence. | Photo courtesy of etectRx.

March 18, 2018 - 6:37pm

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

Mark Johnson

Background:  

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

Gabriel Weisz

Background:  

In this ongoing series, we ask executives, entrepreneurs and business leaders about mistakes that have shaped their business philosophy.

Forest Key

Background:  

Minnesota medtech companies devise treatments for opioid-use disorder

The creators of the InfiSIS, a multimodal neuromodulator device developed by Osseo-based startup SmartImplantSystems specifically as an alternative to opioids, expects the neuropathic device to be effective in addressing the multiple forms of pain that can collectively plague post-operative and other patients, particularly in the back and the legs. | Photo courtesy of Omid Souresrafil/SmartImplantSystems

March 15, 2018 - 4:38pm

Pages